Company: ELV
Filing Date: 2025-02-20
Form Type: 10-K
Source: 0001156039-25-000010
Chunk: 227

Company: Elevance Health, Inc.
Filing Date: 2025-02-20
Form: 10-K
Item: Item 8
Chunk 227
---
 we performed an interim impairment test during the years ended December 31, 2024, 2023 and 2022, and recorded impairment charges of $17, $23 and $34, respectively, for impairment and abandonment of ROU assets which are included in the operating lease expense shown above.Years Ended December 3120242023Other informationOperating cash paid for amounts included in the measurement of lease liabilities, operating leases$202$206ROU assets obtained in exchange for new lease liabilities, operating leases$44$59Weighted average remaining lease term in years, operating leases66Weighted average discount rate, operating leases3.96 %3.66 %At December 31, 2024, future lease payments for noncancelable operating leases with initial or remaining terms of one year or more are as follows:2025$184 2026154 2027127 2028112 2029100 Thereafter209 Total future minimum payments 886 Less imputed interest(75)Total lease liabilities$811 

19. Shareholders’ Earnings per Share

The denominator for basic and diluted shareholders’ earnings per share at December 31, 2024, 2023 and 2022 is as follows:202420232022Denominator for basic shareholders’ earnings per share—weighted-average shares231.7 235.9 240.0 Effect of dilutive securities—employee stock options, non-vested restricted stock awards and convertible debentures1.2 1.5 2.8 Denominator for diluted shareholders’ earnings per share232.9 237.4 242.8 During the years ended December 31, 2024, 2023 and 2022, weighted-average shares related to certain stock options of 0.7, 0.8 and 0.4, respectively, were excluded from the denominator for diluted shareholders’ earnings per share because the stock options were anti-dilutive. 

 -129-

Elevance Health, Inc.Notes to Consolidated Financial Statements (continued)

During each of the years ended December 31, 2024, 2023 and 2022, we issued approximately 0.2 restricted stock units,  of which vesting was contingent upon us meeting certain earnings targets. Contingent restricted stock units are excluded from the denominator for diluted shareholders’ earnings per share and are included only if and when the contingency is met. The 2024 contingent restricted stock units